Keyphrases
2-deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography
33%
Acetazolamide
20%
Adulthood
33%
ANO10
100%
Ataxia
30%
Autosomal Recessive
100%
Biallelic
33%
Brain FDG-PET
33%
CACNA1A Gene
10%
CACNB4
33%
Cerebellar Ataxia
33%
Cerebellar Atrophy
33%
Cerebellar Dysfunction
10%
Cerebellum
33%
Cerebral Magnetic Resonance Imaging
33%
Clinical Data
33%
Compound Heterozygous mutation
33%
Corticospinal Tract
33%
Early Disease
10%
Epilepsy
33%
Episodic Ataxia
20%
Episodic Ataxia Type 2
100%
Executive Impairment
33%
Eye Movement Abnormalities
33%
FDG-PET Scan
33%
Focal Dystonia
100%
Frameshift Variant
10%
Frontal Lobe
33%
Gene Variants
33%
Genetic Data
33%
Heterozygous Variant
33%
Interictal
100%
Metabolic Activity
33%
Myokymia
100%
Novel Variants
33%
Nystagmus
10%
Pathogenic Variants
33%
Pathophysiology
10%
Positron Emission Tomography
33%
Potential Risk
33%
Radiological Data
33%
Risk Genes
33%
Slow Progression
33%
Slurred Speech
10%
Spinocerebellar Ataxia
100%
Symptom Onset
10%
Temporal Lobe Epilepsy
33%
Medicine and Dentistry
Acetazolamide
20%
Ataxia
30%
Autosomal Recessive Inheritance
100%
Cerebellar Ataxia
50%
Cerebellum
50%
Cerebellum Atrophy
50%
Disease
10%
Episodic Ataxia
100%
Eye Movement
50%
Fluorodeoxyglucose F 18
100%
Focal Dystonia
100%
Frontal Lobe
50%
Low Drug Dose
10%
Magnetic Resonance Imaging
50%
Myokymia
100%
Onset Age
10%
Pathophysiology
10%
Positron Emission Tomography
100%
Slurred Speech
10%
Spinocerebellar Ataxia
100%
Symptom
10%
Temporal Lobe Epilepsy
50%
Neuroscience
Acetazolamide
20%
Ataxia
80%
Cerebellum
50%
Dystonia
100%
Episodic Ataxia
100%
Eye Movement
50%
Fluorine-18
100%
Frontal Lobe
50%
Magnetic Resonance Imaging
50%
Positron Emission Tomography
100%
Spinocerebellar Ataxia
100%
Temporal Lobe Epilepsy
50%
